Morgan Stanley’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $35.6M | Buy |
|
|||||
|
2025
Q2 | $28.8M | Buy |
|
|||||
|
2025
Q1 | $26.5M | Buy |
|
|||||
|
2024
Q4 | $19.3M | Buy |
|
|||||
|
2024
Q3 | $12.4M | Buy |
|
|||||
|
2024
Q2 | $13.3M | Sell |
|
|||||
|
2024
Q1 | $19.6M | Sell |
|
|||||
|
2023
Q4 | $50.8M | Buy |
|
|||||
|
2023
Q3 | $6.17M | Buy |
|
|||||
|
2023
Q2 | $2.92M | Buy |
|
|||||
|
2023
Q1 | $1.73M | Sell |
|
|||||
|
2022
Q4 | $2.57M | Buy |
|
|||||
|
2022
Q3 | $2.94M | Buy |
|
|||||
|
2022
Q2 | $1.8M | Buy |
|
|||||
|
2022
Q1 | $1.01M | Buy |
|
|||||
|
2021
Q4 | $1.98M | Buy |
|
|||||
|
2021
Q3 | $223K | Buy |
|
|||||
|
2021
Q2 | $41K | Buy |
|